Brief: SK Biopharmaceuticals Co Q1 Preliminary Operating Profit 89.8 Billion Won Up 249.7% Y/Y
May 7 (Reuters) - SK Biopharmaceuticals Co Ltd 326030.KS: SK BIOPHARMACEUTICALS CO: Q1 PRELIMINARY OPERATING PROFIT 89.8 BILLION WON UP 249.7% Y/Y Source text: [ID:] Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract